Related Experiment Video
Updated: May 14, 2026
16:23
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
Published on: February 26, 2014
[Critical evaluation of interaction screening software available in pharmacies]
S Schillemans1, H De Loof, G R Y De Meyer
1Université d'Anvers, Groupe de recherche en physiopharmacologie, Anvers.
Journal De Pharmacie De Belgique
|January 29, 2013
Summary
Pharmacists face challenges screening patient drug interactions due to complex regimens and flawed software. Recommendations include reducing false positives, improving database updates, and integrating over-the-counter (OTC) medications for better medication safety.
Area of Science:
- Pharmacology
- Health Informatics
Context:
- Increasing complexity of medication regimens.
- Challenges in pharmacist's drug interaction screening.
- Analysis of common software packages in Flanders.
Purpose:
- Evaluate advantages and disadvantages of current drug interaction screening software.
- Identify major limitations in existing pharmaceutical software.
- Provide recommendations for improving medication safety and interaction management.
Summary:
- Current software suffers from false positives, lack of interaction management history, outdated databases, and unclear guidelines.
- Recommendations include reducing signal fatigue via duration-based screening and signal suppression.
- Implement a prescription-register log, enhance software support, expedite database updates, and include OTC medications and supplements in patient records.
Impact:
- Aims to reduce medication errors and improve patient outcomes.
- Enhance the efficiency and effectiveness of pharmacists' drug interaction screening.
- Promote better pharmacovigilance through improved software functionality and pharmacist knowledge.
More Related Videos
Related Concept Videos
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:12Statistical Software for Data Analysis and Clinical Trials
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...